# Kiniksa Pharmaceuticals International, plc (KNSA) — Revenue

## Annual Revenue (USD)

| Year | Revenue |
| --- | --- |
| 2025 | $678M |
| 2024 | $423M |
| 2023 | $270M |
| 2022 | $220M |
| 2021 | $39M |

## Quarterly Revenue (USD)

| Quarter | Revenue |
| --- | --- |
| 2026-03-31 | $214M |
| 2025-09-30 | $181M |
| 2025-06-30 | $157M |
| 2025-03-31 | $138M |
| 2024-09-30 | $112M |
| 2024-06-30 | $109M |
| 2024-03-31 | $80M |
| 2023-09-30 | $67M |
| 2023-06-30 | $71M |
| 2023-03-31 | $48M |
| 2022-09-30 | $99M |
| 2022-06-30 | $27M |
| 2022-03-31 | $32M |
| 2021-09-30 | $12M |
| 2021-06-30 | $8M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/KNSA/revenue)